ftInvstr

NECLIFE · Healthcare ₹10.29 +0.1% Mkt Cap ₹198 Cr

NECLIFE

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹10.29

+0.1% today · 30d +1.28%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for NECLIFE. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-03-31

REVENUE

₹0 Cr

-100.0% YoY

NET PROFIT

₹-68 Cr

OPM

-672.1%

-636.3pp YoY

EPS

₹-1.85

PE 29.29

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-182.3% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

NECLIFE29.29-5.0

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 5

Valuation REASONABLE 60

Growth DECLINING 27

Profitability LOW 5

Technicals NEUTRAL 55

Risk LOW 90

Key Stats

TTM PE

29.29

P/B

0.35

52W HIGH

₹22.4

OFF HIGH

-54.06%

DIV YIELD

0.0%

MKT CAP

₹198 Cr

◉ Active Signals

MACDNeutral0.005

RSI(14)Neutral45.61

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold NECLIFE and at what entry.